H3 mRNA / LNP Vaccine (Sanofi Pasteur)

N/A

Report date: 2023/04/27 20:00:28

Base Information

Drug NameH3 mRNA / LNP Vaccine (Sanofi Pasteur)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofi Pasteur
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A